SCIENCE & REAL-WORLD EVIDENCE
We didn't start with AI. We started with evidence.
More than a decade of research in continence, pelvic health and connected care — from clinical studies and real-world evidence to large-scale datasets and AI-enabled insights.
Research conducted with healthcare professionals, hospitals, universities and clinical partners across Europe, Asia and Australia.
That is supported well by the scientific work: for example, the ICS 2021 Carin work includes Luigi Sacco Hospital, Perugia University Hospital, Women's Clinic LUNA Next Stage and National University Health System Singapore alongside LSG and other partners.
SCIENCE & REAL-WORLD EVIDENCE
Years of clinical research and real-world data are helping LifeSense understand continence differently — measuring what happens in everyday life, learning from patterns and turning those insights into increasingly personalised support.
18,921
CHILDREN IN LATEST REAL-WORLD DATASET
1M+
ENURESIS & SLEEP DATA POINTS
115
WOMEN IN MULTI-COUNTRY CARIN STUDIES
2019 → 2026
CONTINUOUS CLINICAL & REAL-WORLD RESEARCH
HOW WE BUILD KNOWLEDGE
TECHNICAL VALIDATION
Can the sensing technology capture relevant events reliably and consistently?
USABILITY AND EXPERIENCE
Can people use the technology comfortably and confidently in everyday life?
BEHAVIOR AND ENGAGEMENT
How do guidance, feedback and connected support influence participation over time?
CLINICAL RELEVANCE
How can the technology and resulting information contribute to care, research or professional decision-making?
LONGITUDINAL LEARNING
What patterns become visible when meaningful observations accumulate over time?
RESEARCH AREAS
BEDWETTING AND PEDIATRIC CONTINENCE — Research relating to connected bedwetting support, behavioral guidance, family experience and future opportunities for pattern recognition.
WOMEN’S PELVIC HEALTH — Research relating to pelvic-floor support, connected sensing, guided training, engagement and women’s health experiences.
MEN’S CONTINENCE — Research relating to connected support for men experiencing urinary leakage and the development of accessible, discreet solutions.
PROFESSIONAL CONTINENCE SUPPORT — Research exploring how connected information, personalized programs and healthcare professionals may work together.
NEXT-GENERATION HEALTH SENSING — Research and development exploring smart textiles, biosensing and new forms of meaningful health information.
SELECTED EVIDENCE
CHILDREN'S CONTINENCE - From 2,421 to 18,921 children
2021
2,421 children
First large-scale Oopsie Heroes study presented at ICS.
The study included 2,421 children; detailed longitudinal event data were available for a subset of 403 children.
↓
2022
7,461 children
Dataset expands across children aged 3–16.
Detailed event data were analysed for 4,108 users, with data collected for up to three months.
↓
2025
17,159 children · 1M+ data points
Real-world evidence enters a new scale.
The NCOI work reports more than one million data points and a measured subgroup of 4,800 children showing decreased enuresis frequency and improved bladder control/retention.
↓
2026
18,921 CHILDREN
From real-world evidence to AI-derived insight.
Machine-learning analysis identifies temporal patterns, response trajectories and distinct enuresis phenotypes, while exploring personalised wake-up strategies.
RESEARCH LIBRARY
Every measurement creates more than a datapoint. Together, longitudinal measurements reveal patterns — when events happen, how behaviour changes, who responds, and how quickly.
LifeSense is using this growing evidence base to move from detecting events toward understanding patterns, predicting outcomes and personalising support.
PATTERN RECOGNITION
Identify recurring behavioural and physiological patterns.
PREDICTIVE INSIGHT
Model response trajectories and anticipate events.
PERSONALISED SUPPORT
Adapt interventions to the individual rather than the average user.
DATA AND AI
Useful intelligence begins with meaningful data.
Connected technologies can generate information in the context of everyday life. When relevant observations accumulate over time, they may reveal patterns that are difficult to see from isolated events. LifeSense Group is exploring how responsible data use and appropriate analytical methods can support a deeper understanding of continence and pelvic health.
We did not add AI to a continence product. We built the connected foundation needed to learn from real-world data.
The role of data and AI is to support understanding and increasingly personalized care—not to replace healthcare professionals or clinical judgment.
RESEARCH WITHOUT BORDERS
Our evidence has been developed and presented through collaborations spanning clinical care, research and real-world use across multiple continents.
Netherlands · Italy · Japan · Singapore · Australia · Taiwan
Luigi Sacco Hospital — Milan
Women's Clinic LUNA Next Stage — Japan
National University Health System — Singapore
Biomedical Devices — Australia
LifeSense Group — Netherlands
The ICS publication documents the international clinical collaboration directly.
CLINICAL AND OBSERVATIONAL RESEARCH · TECHNOLOGY VALIDATION · USABILITY AND HUMAN-FACTORS RESEARCH · SMART-TEXTILE AND SENSING DEVELOPMENT · LONGITUDINAL REAL-WORLD DATA · DIGITAL-HEALTH ENGAGEMENT · RESPONSIBLE DATA SCIENCE
OUR PRINCIPLES
RELEVANCE — Research should address meaningful technical, human or healthcare questions.
TRANSPARENCY — Findings should be presented with appropriate context, methods and limitations.
COLLABORATION — Strong digital-health research connects technology, healthcare knowledge and lived experience.
RESPONSIBILITY — Health data and intelligent systems require careful governance, privacy and human oversight.
SCIENCE AT LIFESENSE
LifeSense Group combines connected technology, research and real-world learning to help move continence care from reactive support toward deeper understanding, prediction and personalization.
LIFESENSE GROUP
Smart Solutions. Healthier Lives.